Patent US2459615A successfully refreshed from Google Patents.
Patent US5080675A successfully refreshed from Google Patents.
Patent US4044602A successfully refreshed from Google Patents.
Patent US4632119A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4632119A Expired / Lapsed US ⏱️ 0.0 years remaining

Ambulatory esophageal pH monitor

Assignee: HERMAN M FINCH UNIVERSITY OF HEALTH SCIENCES/THE CHICAGO MEDICAL SCHOOL
•
Filing: 1985-10-23
•
Granted: 1986-12-30
•
Expires: 2005-10-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A unique ingestible and retrievable ambulatory esophageal monitor for colorimetric analysis of ambient pH within selected portions of the esophagus comprising a nasoesophgeal conduit at least one generally transparent semi-permeable envelope carried proximal the distal end of the conduit for positioning within the distal esophagus. The envelope contains an ion exchange color indicator composition comprised of a weak cation exchange substance selected from the group comprising a resin, a cellulose or an agarose and intermixed and bound therein being an indicator dye preferably either methylene blue or azure A. The ion exchange substance having a disassociation potential (pK) of at least 4 so that the indicator dye selectively disassociates causing the envelope to visually discolorize when exposed to a clinically significant ambient pH of 4 or less within the esophagus.

Inventors

  • 👤 Benjamin J. Reichstein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:06
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/42; A61B5/07; A61B5/073; A61B5/4222; A61B5/4233

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 181 words
A self-contained diagnostic pH monitor for preliminary screening of gastroesophageal reflux disease and suitable for esophageal intubation without restriction of patient movement and activity, the monitor determining duration of exposure to pH levels clinically significant for gastroesophageal reflux disease, the monitor omitting use of external power, light and data processing sources, comprising: a nasoesophageal probe for selected esophageal intubation, the probe having a length permitting positioning of a distal end of the probe proximal to the gastroesophageal junction of the esophagus; at least one semipermeable envelope, the envelope being carried near the distal end of the probe, the envelope containing a composition including a cation exchange substance having an ionic dye bound thereto, the envelope being constructed of a material permeable to both hydronium ions and the ionic dye; said composition substantially and irreversibly discoloring in response to extended exposure to a pH of 4 or less and upon withdrawal of the probe the composition in said envelope being colorimetrically analyzable to semi-quantitatively determine the duration of exposure to pH levels being clinically significant for preliminary screening of gastroesophageal reflux disease.
Claim 2
Dependent Claim 181 words
A self-contained diagnostic pH monitor for preliminary screening of gastroesophageal reflux disease and suitable for esophageal intubation without restriction of patient movement and activity, the monitor determining duration of exposure to pH levels clinically significant for gastroesophageal reflux disease, the monitor omitting use of external power, light and data processing sources, comprising: a nasoesophageal probe for selected esophageal intubation, the probe having a length permitting positioning of a distal end of the probe proximal to the gastroesophageal junction of the esophagus; at least one semipermeable envelope, the envelope being carried near the distal end of the probe, the envelope containing a composition including a cation exchange substance having an ionic dye bound thereto, the envelope being constructed of a material permeable to both hydronium ions and the ionic dye; said composition substantially and irreversibly discoloring in response to extended exposure to a pH of 4 or less and upon withdrawal of the probe the composition in said envelope being colorimetrically analyzable to semi-quantitatively determine the duration of exposure to pH levels being clinically significant for preliminary screening of gastroesophageal reflux disease.
Claim 3
Dependent Claim 18 words
The pH monitor of claim 1 wherein the cationic exchange substance has a pK of at least 4.
Claim 4
Dependent Claim 19 words
The pH monitor of claim 2 wherein the cationic exchange substance has a pK of between 4 and 5.
Claim 5
Dependent Claim 25 words
The pH monitor of claim 1 wherein the cationic exchange substance is selected from the group consisting of a resin, a cellulose and an agarose.
Claim 6
Dependent Claim 22 words
The pH monitor of claim 1 wherein the ionic dye is selected from the group consisting of methylene blue and azure A.
Claim 7
Dependent Claim 30 words
The pH monitor of claim 1 further including a second semi-permeable envelope carried proximal to the one semi-permeable envelope, said second semi-permeable envelope being generally intermediately positioned along the probe.
Claim 8
Dependent Claim 13 words
The pH monitor of claim 1 wherein the probe includes a nasoesophageal catheter.

References Cited (Backward Citations)

US2664879A Cited
US3097636A Cited
US3373735A Cited
US3483859A Cited
US3528429A Cited
US4029598A Cited
US4200110A Cited
US4381011A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-12-29 1990-06-30 1990-12-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-12-29 1994-06-30 1994-12-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-12-29 1998-06-30 1998-12-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag